Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > au contraire canadafan

<< Previous

Bullboard Posts

Next >>

Post by pelabooston Feb 29, 2024 11:05am

159 Views

Post# 35906519

au contraire canadafan

Two important changes that make sense: New Arm GOBLET, and Expansion of Anal Cohort GOBLET. I suppose you could add new board member to that.

By the way itntdf; crawfish boil is a Canadian thing, started by the Acadians.

I have no clue what is going on, except to say if this holds it beats the last few mmonths.

<< Previous

Bullboard Posts

Next >>

The top 10 artificial intelligence penny stocks